about
Essent Biologics is a nonprofit biotechnology company setting a new standard in human-derived biomaterials and comprehensive data for research.
Starting with the donor, Essent Biologics acts as the catalyst to advance regenerative medicine, biopharmaceutical and cell therapy research from benchtop to bedside.
We provide living, human biomaterials for researchers in cell therapy and regenerative medicine
fostering research =
revolutionizing therapies
Our products are the catalyst to elevate your research.
GMP processed and robust donor eligibility criteria reduce many of the barriers.
explore our product lines
service
+ discovery
Whether your research is in the early stages of experimentation or you’re approaching clinical development, Essent Biologics is here to help. Our team brings over 120 years of biotechnology experience and a collaborative spirit to help you find the ideal human cell type or scaffold material.
our difference
As a strategic venture from AlloSource, an FDA compliant tissue bank (under 21 CFR Part 1271) with more than 25 years of experience, Essent Biologics leverages that experience to provide better biological materials and data to empower your research.
This relationship enables us to source primary cells, scaffold materials and research tissue.
We maximize the gift of tissue donation by providing an array of human primary cells to help scientists recapitulate the physiological state of cells in vivo and generate more relevant data about human biology.
– Chief Scientist, Jeff Brown, Ph.D.
Just as punctuation gives clarity and structure to text, Essent Biologics’ products will create precision and results in your research. Consistent inputs and reliable supply of human biological materials, along with comprehensive data, means less variability for your research. Period.
Essent Biologics is partnering with AlloSource, an FDA compliant tissue bank (under 21 CFR Part 1271), to provide you with quality human primary cells, scaffold materials and tissue for research. This collaborative relationship allows us to source novel biological materials and design them to suit your specific research needs.
We know there are many paths to choose from when climbing the mountain that is research – from concept to market. Essent’s highly-characterized* human mesenchymal stem cells (MSC) allow you to ascend that mountain faster and more easily. Our reliable supply of biological materials produced under GMP-compliant processes means the sky’s the limit when exploring research opportunities. Let us get you started or keep you moving.
*Cell characterization includes results for cell population doubling level, tri-lineage differentiation, flow cytometry markers, cell viability and morphology, growth characteristics and potency.
We understand utilizing animal-derived cells and products may limit confidence in your research due to the lack of biological relevancy. Our goal is to remove limitations and give you access to human primary cells, scaffold materials and data essential to your research.
Essent Biologics’ human-derived biomaterials can provide additional confidence to advance to human clinical trials faster. We know your goal is to develop new medical solutions, and as a source for GMP-compliant biological materials, we prioritize accelerating your research through human clinical trials.
The work Essent is doing to help accelerate research through human clinical trials is remarkable. We are excited to partner with such an innovative company who will support research to develop new medical solutions, and we look forward to their future growth.
– Ethan Mann, CEO of Validus Cellular Therapeutics, Inc.
Essent was absolutely critical to helping us move our research forward. We partnered with the team on a shoulder degeneration study, and they didn’t hesitate to find a way to provide us with the tissue we needed. Access to the tissue supplied by Essent represents a paradigm shift in our ability to analyze and correlate the genetic, structural, mechanical and histological changes observed in human patients suffering from tendinopathy. To our knowledge, this is the first time this type of donor tissue has been available to researchers. We could not be more grateful for their support.
– Kirk McGilvary, Ph.D., Associate Director Orthopaedic Bioengineering Research Laboratory of Colorado State University
Essent Biologics walks the talk of diversity, equity and inclusion (DEI) by fostering a culture of openness, collaboration and creativity. We are proud to work with such a forward-thinking team. DEI is embedded in the startup phase of the company’s lifecycle and foundational to their long-term success.
– Robin Szeliga, Principal, Action Consulting